Announced

Boston Scientific to acquire Lumenis from BPEA for $1.07bn.

Synopsis

Boston Scientific, a manufacturer of medical devices, agreed to acquire Lumenis, a privately-held company that develops and commercializes energy-based medical solutions, from Baring Private Equity Asia, a private equity firm, for $1.07bn. Boston Scientific expects to complete the transaction in the second half 2021 and sees no material impact to its annual adjusted earnings from the deal. "The acquisition will expand our global footprint throughout Europe and Asia and accelerate the delivery of our robust stone management offerings to more urologists – ultimately serving more patients worldwide – while also improving our top-line growth and margins," Meghan Scanlon, Boston Scientific Senior Vice President and President of Urology and Pelvic Health.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US